RXRXRecursion Pharmaceuticals, Inc.May 6, 2026Q1 2026
Read transcript →Recursion Pharmaceuticals, Inc. (RXRX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$3.34
+4.87%
Mkt Cap $1.60B
RXRXRecursion Pharmaceuticals, Inc.May 6, 2026RXRXRecursion Pharmaceuticals, Inc.Feb 25, 2026Q4 2025
Read transcript →RXRXRecursion Pharmaceuticals, Inc.Nov 5, 2025Q3 2025
Read transcript →RXRXRecursion Pharmaceuticals, Inc.Aug 5, 2025Q2 2025
Read transcript →RXRXRecursion Pharmaceuticals, Inc.May 5, 2025Q1 2025
Read transcript →RXRXRecursion Pharmaceuticals, Inc.Feb 28, 2025Q4 2024
Read transcript →RXRXRecursion Pharmaceuticals, Inc.Aug 9, 2024Q2 2024
Read transcript →RXRXRecursion Pharmaceuticals, Inc.May 9, 2024Q1 2024
Read transcript →RXRXRecursion Pharmaceuticals, Inc.Feb 27, 2024Q4 2023
Read transcript →